OwnbyRL, CroccoE, AcevedoA, Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006;63:530–538.10.1001/archpsyc.63.5.530)| false
de QuervainDJ-F, HenkeK, AerniA, et al.Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe. Eur J Neurosci2003;17:1296–1302.
de QuervainDJ-F, HenkeK, AerniA, Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe. Eur J Neurosci 2003;17:1296–1302.10.1046/j.1460-9568.2003.02542.x)| false
AggletonJP, PralusA, NelsonAJ, Thalamic pathology and memory loss in early Alzheimer's disease: moving the focus from the medial temporal lobe to Papez circuit. Brain 2016;139:1877–1890.10.1093/brain/aww083)| false
EndoY, NishimuraJI, KobayashiS, et al.Long-term glucocorticoid treatments decrease local cerebral blood flow in the rat hippocampus, in association with histological damage. Neuroscience1997;79:745–752.
EndoY, NishimuraJI, KobayashiS, Long-term glucocorticoid treatments decrease local cerebral blood flow in the rat hippocampus, in association with histological damage. Neuroscience 1997;79:745–752.10.1016/S0306-4522(97)00044-4)| false
ArrizaJL, WeinbergerC, CerelliG, Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987;237:268–275.10.1126/science.3037703)| false
TakahashiS, TanizakiY, KimuraH, et al.Comparison of cerebral blood flow data obtained by computed tomography (CT) perfusion with that obtained by xenon CT using 320-row CT. J Stroke Cerebrovasc Dis2015;24:635–641.
TakahashiS, TanizakiY, KimuraH, Comparison of cerebral blood flow data obtained by computed tomography (CT) perfusion with that obtained by xenon CT using 320-row CT. J Stroke Cerebrovasc Dis 2015;24:635–641.10.1016/j.jstrokecerebrovasdis.2014.10.010)| false
ScheelM, StröhleA, BruhnH. Effects of short-term stresslike cortisol on cerebral metabolism: a proton magnetic resonance spectroscopy study at 3.0 T. J Psychiatr Res 2010;44:521–526.10.1016/j.jpsychires.2009.11.010)| false
AbbsB, LiangL, MakrisN, Covariance modeling of MRI brain volumes in memory circuitry in schizophrenia: sex differences are critical. Neuroimage 2011;56:1865–1874.10.1016/j.neuroimage.2011.03.079)| false
FastR, SchüttT, ToftN, An observational study with long-term follow-up of canine cognitive dysfunction: clinical characteristics, survival, and risk factors. J Vet Intern Med 2013;27:822–829.10.1111/jvim.12109)| false
FisetP, PausT, DalozeT, Brain mechanisms of propofol-induced loss of consciousness in humans: a positron emission tomographic study. J Neurosci 1999;19:5506–5513.10.1523/JNEUROSCI.19-13-05506.1999)| false
HarperAM. Autoregulation of cerebral blood flow: influence of the arterial blood pressure on the blood flow through the cerebral cortex. J Neurol Neurosurg Psychiatry 1966;29:398–403.10.1136/jnnp.29.5.398)| false
PeremansK, AudenaertK, BlanckaertP, et al.Effects of aging on brain perfusion and serotonin-2A receptor binding in the normal canine brain measured with single-photon emission tomography. Prog Neuropsychopharmacol Biol Psychiatry2002;26:1393–1404.
PeremansK, AudenaertK, BlanckaertP, Effects of aging on brain perfusion and serotonin-2A receptor binding in the normal canine brain measured with single-photon emission tomography. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:1393–1404.10.1016/S0278-5846(02)00306-8)| false
To examine whether glucocorticoid (GC) administration alters hippocampal cerebral blood flow (CBF) or volume in dogs.
6 clinically normal adult Beagles.
Each dog underwent CT and MRI to measure the CBF in the hippocampus, basal ganglia, thalamus, and cerebral cortex and the volume of the hippocampus in each hemisphere of the brain before (day 0) and during (days 7 and 21) a 21-day treatment with prednisolone (1.0 mg/kg, PO, q 24 h) and famotidine (0.5 mg/kg, PO, q 12 h). Results for hippocampal volume, anesthesia-related variables, and semiquantitative measurements of CBF (hemisphere-specific ratios of the CBF in the hippocampus, basal ganglia, and thalamus relative to the CBF in the ipsilateral cerebral cortex and the left cerebral cortex CBF-to-right cerebral cortex CBF ratio) were compared across assessment time points (days 0, 7, and 21).
The ratios of CBF in the right hippocampus and right thalamus to that in the right cerebral cortex on day 21 were significantly lower than those on day 0. No meaningful differences were detected in results for the hippocampal volume in either hemisphere or for the anesthesia-related variables across the 3 time points.
CONCLUSIONS AND CLINICAL RELEVANCE
Results indicated that GC administration reduced CBF in the hippocampus and thalamus in dogs of the present study, similar to that which occurs in humans. Research on GC-related brain alteration in dogs could potentially contribute to advancements in understanding Alzheimer disease in humans and neurodegenerative conditions in dogs.